← FDA Drug Approvals (Drugs@FDA)
CYMBALTA
NDA · New Drug Application · Sponsor: LILLY · Approved 2004-08-03
Drug application
- FDA Application #
NDA021427- Application type
- New Drug Application
- Brand name
- CYMBALTA
- Generic name
- DULOXETINE HYDROCHLORIDE
- Active ingredients
- DULOXETINE HYDROCHLORIDE
- Dosage form
- CAPSULE, DELAYED REL PELLETS
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LILLY
- Manufacturer
- Eli Lilly and Company
- First approval
- 2004-08-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown